Moore Duncan's Form 4 filing
ASP Isotopes Inc.ASPI · filed Apr 17, 2026
- Accession no.
- 0001477932-26-002387
- Filed
- Apr 17, 2026
- Trade date
- Nov 12, 2025-Apr 16, 2026
- Filing delay
- 156 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $60.7K. It was filed 156 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Moore DuncanCIK 0001888265 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | Common Stock | AGrant or awardAcquired | +25,469 | –F1 | – | 1,020,022 | Direct | |
| Dec 18, 2025 | Common Stock | AGrant or awardAcquired | +36,548 | –F2 | – | 1,056,570 | Direct | |
| Apr 16, 2026 | Common Stock | SSaleDisposed | −11,642 | $5.21F4 | −$60,654.82 | 1,044,928 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Award of shares of restricted stock in connection with the reporting person's service as an independent director of ASP Isotopes Inc. on the QLE Structuring and Strategic Transactions Committee.
Referenced by the price of 1 transaction in Table I.
- F2
2025 annual award of shares of restricted stock in connection with the reporting person's service as an independent director of ASP Isotopes Inc.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.055 to $5.52, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2.
Referenced by the price of 1 transaction in Table I.